What are the categories of the Rutherford classification for acute limb ischemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rutherford Classification for Acute Limb Ischemia

The Rutherford classification divides acute limb ischemia into three main categories (I, II, and III) based on limb viability, sensory loss, motor weakness, and Doppler signals, with Category II further subdivided into IIa and IIb to guide urgency of revascularization. 1

Classification Categories

Category I: Viable

  • Limb is not immediately threatened 1
  • No sensory loss 1
  • No muscle weakness 1
  • Audible arterial and venous Doppler signals 1
  • Revascularization should be performed on an urgent basis within 6-24 hours 1

Category IIa: Marginally Threatened

  • Limb is salvageable if promptly treated 1
  • Mild-to-moderate sensory loss limited to toes 1
  • No motor loss 1
  • Inaudible arterial Doppler but audible venous Doppler signals 1
  • Requires emergent revascularization within 6 hours 1

Category IIb: Immediately Threatened

  • Limb is salvageable if urgently treated 1
  • Sensory loss extending beyond the toes 1
  • Mild-to-moderate motor weakness 1
  • Inaudible arterial but audible venous Doppler signals 1
  • Requires emergent revascularization within 6 hours 1
  • Fasciotomy should be considered if time to revascularization exceeds 4 hours 1

Category III: Irreversible

  • Major tissue loss or permanent nerve damage inevitable 1
  • Profound sensory loss (anesthetic) 1
  • Profound muscle weakness or paralysis (rigor) 1
  • Inaudible arterial and venous Doppler signals 1
  • Amputation should be performed as the first procedure 1
  • Revascularization is contraindicated due to risk of reperfusion injury causing multiorgan failure and cardiovascular collapse 1

Clinical Application

The classification directly determines treatment urgency and modality. Categories IIa and IIb require emergent intervention within 6 hours, while Category I allows for urgent treatment within 6-24 hours. 1 Category III limbs should not undergo revascularization attempts. 1

Higher Rutherford categories correlate with worse clinical outcomes. Recent data demonstrates that Rutherford IIb and III ischemia independently predicts worse amputation-free survival (HR 1.86) compared to lower categories. 2 Patients with Category I ischemia who undergo catheter-directed thrombolysis have more favorable functional outcomes than those with Category II ischemia. 3

The classification relies on objective physical examination findings including assessment of sensory function, motor function, and Doppler signals in both arterial and venous systems, making it reproducible and clinically practical for rapid bedside assessment. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Catheter-Directed Thrombolysis for (Not Immediately) Threatened Acute Lower Limb Ischemia: Clinical Outcome and Efficacy.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.